Why the study?
Does tocainide improve symptoms in a patient with recessive generalized congenital myotonia?
Population
1 patient with recessive generalized congenital myotonia and severe, disabling weakness
Comparison
Tocainide (up to 1,600 mg per day) vs Phenytoin, verapamil, and acetazolamide
Design
Case_report
Authors
Loading...
Tocainide may warrant trial in refractory recessive myotonia; hypothesis-generating and requires controlled confirmation.
Does tocainide improve symptoms in a patient with recessive generalized congenital myotonia?
Tocainide may be an effective treatment for recessive generalized congenital myotonia when other agents fail, though limited by dose-dependent side effects.
Erich W. Streib (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: